Covidien Initiates Nationwide Voluntary Recall of Sodium Chromate Cr-51 Injection, Lot #370-9004

["U.S. Food & Drug Administration (FDA)" <fda@xxxxxxxxxxxxxxxxxxxxxxx>]

Title: Covidien Initiates Nationwide Voluntary Recall of Sodium Chromate Cr-51 Injection, Lot #370-9004

Covidien Initiates Nationwide Voluntary Recall of Sodium Chromate Cr-51 Injection, Lot #370-9004
Thu, 09 Jul 2009 20:41:00 -0500

Covidien announced that its Mallinckrodt Inc. subsidiary is voluntarily recalling one lot of Mallinckrodt Sodium Chromate Cr-51 Injection, lot #370-9004 as a result of routine post-market testing in which the product was found to be subpotent.

---

Manage your FDA Subscriptions:

• Update your preferences or unsubscribe
• Questions about this service? support@xxxxxxxxxxxxxxx
• Other inquiries? webmail@xxxxxxxxxx

GovDelivery, Inc. sending on behalf of U.S. Food & Drug Administration (FDA) · 5600 Fishers Lane · Rockville MD 20857 · 800-439-1420